Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Yap

Showing results (61-70 of 260) with videos related to

Pageof 26
Sort By:
Nature Reviews. Cancer|July 26, 2017
Novel insights into mesothelioma biology and implications for therapyTimothy A Yap, Joachim G Aerts, Sanjay Popat, et al.
Nature Reviews. Clinical Oncology|October 26, 2018
State-of-the-art strategies for targeting the DNA damage response in cancerPatrick G Pilié, Chad Tang, Gordon B Mills, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Opportunities and pitfalls of targeted therapeutic combinations in solid tumorsJoaquin Mateo, Michael Ong, Timothy A Yap, et al.
Pharmacology & Therapeutics|April 24, 2025
USP1 inhibition: A journey from target discovery to clinical translationCarlos Torrado, Nicholas W Ashton, Alan D D'Andrea, et al.
Contemporary Clinical Trials|March 12, 2021
Shotgun: A Bayesian seamless phase I-II design to accelerate the development of targeted therapies and immunotherapyLiyun Jiang, Ruobing Li, Fangrong Yan, et al.
Expert Opinion on Investigational Drugs|November 18, 2008
Reovirus therapy in cancer: has the orphan virus found a home?Timothy A Yap, Andre Brunetto, Hardev Pandha, et al.
Expert Opinion on Drug Discovery|March 15, 2013
Targeting cell cycle kinases and kinesins in anticancer drug developmentTimothy A Yap, L Rhoda Molife, Sarah P Blagden, et al.
Pharmacogenomics and Personalized Medicine|December 3, 2021
Clinical Development of AKT Inhibitors and Associated Predictive Biomarkers to Guide Patient Treatment in Cancer MedicineNiamh Coleman, Justin T Moyers, Alice Harbery, et al.
Science Translational Medicine|March 31, 2012
Intratumor heterogeneity: seeing the wood for the treesTimothy A Yap, Marco Gerlinger, P Andrew Futreal, et al.
Nature Reviews. Cancer|June 11, 2010
Envisioning the future of early anticancer drug developmentTimothy A Yap, Shahneen K Sandhu, Paul Workman, et al.
Pageof 26

Showing results (61-70 of 260) with videos related to

Sort By:
Pageof 26
Nature Reviews. Cancer|July 26, 2017
Novel insights into mesothelioma biology and implications for therapyTimothy A Yap, Joachim G Aerts, Sanjay Popat, et al.
Nature Reviews. Clinical Oncology|October 26, 2018
State-of-the-art strategies for targeting the DNA damage response in cancerPatrick G Pilié, Chad Tang, Gordon B Mills, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Opportunities and pitfalls of targeted therapeutic combinations in solid tumorsJoaquin Mateo, Michael Ong, Timothy A Yap, et al.
Pharmacology & Therapeutics|April 24, 2025
USP1 inhibition: A journey from target discovery to clinical translationCarlos Torrado, Nicholas W Ashton, Alan D D'Andrea, et al.
Contemporary Clinical Trials|March 12, 2021
Shotgun: A Bayesian seamless phase I-II design to accelerate the development of targeted therapies and immunotherapyLiyun Jiang, Ruobing Li, Fangrong Yan, et al.
Expert Opinion on Investigational Drugs|November 18, 2008
Reovirus therapy in cancer: has the orphan virus found a home?Timothy A Yap, Andre Brunetto, Hardev Pandha, et al.
Expert Opinion on Drug Discovery|March 15, 2013
Targeting cell cycle kinases and kinesins in anticancer drug developmentTimothy A Yap, L Rhoda Molife, Sarah P Blagden, et al.
Pharmacogenomics and Personalized Medicine|December 3, 2021
Clinical Development of AKT Inhibitors and Associated Predictive Biomarkers to Guide Patient Treatment in Cancer MedicineNiamh Coleman, Justin T Moyers, Alice Harbery, et al.
Science Translational Medicine|March 31, 2012
Intratumor heterogeneity: seeing the wood for the treesTimothy A Yap, Marco Gerlinger, P Andrew Futreal, et al.
Nature Reviews. Cancer|June 11, 2010
Envisioning the future of early anticancer drug developmentTimothy A Yap, Shahneen K Sandhu, Paul Workman, et al.
Pageof 26